Schmidt CM - Search Results

1

Response of Locally Advanced Pancreatic Cancer to Intratumoral Injection of Large Surface Area Microparticle Paclitaxel: Initial Report of Safety and Clinical Outcome.

Sharma NR, Lo SK, Hendifar A, Othman MO, Patel K, Mendoza-Ladd A, Verco S, Maulhardt HA, Verco J, Wendt A, Marin A, Schmidt CM, diZerega G. Sharma NR, et al. Among authors: schmidt cm. Pancreas. 2023 Mar 1;52(3):e179-e187. doi: 10.1097/MPA.0000000000002236. Pancreas. 2023. PMID: 37782888 Clinical Trial.

2

The role of nuclear factor kappaB in pancreatic cancer and the clinical applications of targeted therapy.

Holcomb B, Yip-Schneider M, Schmidt CM. Holcomb B, et al. Among authors: schmidt cm. Pancreas. 2008 Apr;36(3):225-35. doi: 10.1097/MPA.0b013e31815b3207. Pancreas. 2008. PMID: 18362834 Review.

3

Transforming growth factor α levels in pancreatic fluid.

Doyle CJ, Agaram NP, Yip-Schneider MT, Schmidt CM. Doyle CJ, et al. Among authors: schmidt cm. Pancreas. 2011 Mar;40(2):260-4. doi: 10.1097/mpa.0b013e3181f94d2a. Pancreas. 2011. PMID: 21404459

4

The proteome of normal pancreatic juice.

Doyle CJ, Yancey K, Pitt HA, Wang M, Bemis K, Yip-Schneider MT, Sherman ST, Lillemoe KD, Goggins MD, Schmidt CM. Doyle CJ, et al. Among authors: schmidt cm. Pancreas. 2012 Mar;41(2):186-94. doi: 10.1097/MPA.0b013e31822862f6. Pancreas. 2012. PMID: 22129531 Free PMC article.

5

Efficacy of dimethylaminoparthenolide and sulindac in combination with gemcitabine in a genetically engineered mouse model of pancreatic cancer.

Yip-Schneider MT, Wu H, Hruban RH, Lowy AM, Crooks PA, Schmidt CM. Yip-Schneider MT, et al. Among authors: schmidt cm. Pancreas. 2013 Jan;42(1):160-7. doi: 10.1097/MPA.0b013e318254f455. Pancreas. 2013. PMID: 22699205

6

Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm.

Ceppa EP, Roch AM, Cioffi JL, Sharma N, Easler JJ, DeWitt JM, House MG, Zyromski NJ, Nakeeb A, Schmidt CM. Ceppa EP, et al. Among authors: schmidt cm. Surgery. 2015 Oct;158(4):937-44; discussion 944-5. doi: 10.1016/j.surg.2015.06.003. Epub 2015 Jul 11. Surgery. 2015. PMID: 26173683

7

Utility of DNA Profiling From Main Pancreatic Duct Fluid by Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatography to Screen for Malignant Potential.

Simpson RE, Flick KF, Gromski MA, Al-Haddad MA, Easler JJ, Sherman S, Fogel EL, Schmidt CM, DeWitt JM. Simpson RE, et al. Among authors: schmidt cm. Pancreas. 2020 May/Jun;49(5):714-722. doi: 10.1097/MPA.0000000000001549. Pancreas. 2020. PMID: 32433411

8

A Quantitative Global Proteomics Approach Identifies Candidate Urinary Biomarkers That Correlate With Intraductal Papillary Mucinous Neoplasm Dysplasia.

Flick KF, Yip-Schneider MT, Sublette CM, Simpson RE, Colgate CL, Wu H, Soufi M, Dewitt JM, Mosley AL, Ceppa EP, Zhang J, Schmidt CM. Flick KF, et al. Among authors: schmidt cm. Pancreas. 2020 Sep;49(8):1044-1051. doi: 10.1097/MPA.0000000000001628. Pancreas. 2020. PMID: 32769857

9

MEK inhibition of pancreatic carcinoma cells by U0126 and its effect in combination with sulindac.

Yip-Schneider MT, Schmidt CM. Yip-Schneider MT, et al. Among authors: schmidt cm. Pancreas. 2003 Nov;27(4):337-44. doi: 10.1097/00006676-200311000-00012. Pancreas. 2003. PMID: 14576498

10

Effect of celecoxib and the novel anti-cancer agent, dimethylamino-parthenolide, in a developmental model of pancreatic cancer.

Yip-Schneider MT, Wu H, Njoku V, Ralstin M, Holcomb B, Crooks PA, Neelakantan S, Sweeney CJ, Schmidt CM. Yip-Schneider MT, et al. Among authors: schmidt cm. Pancreas. 2008 Oct;37(3):e45-53. doi: 10.1097/MPA.0b013e318172b4dd. Pancreas. 2008. PMID: 18815538

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

430 results

Search Page